OSUR · Orasure Technologies Inc
Market Cap
$240.01M
Shares
68.97M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$115.02M
-38.1%
FY2025
Net Income
-$68.73M
-252.5%
FY2025
Gross Margin
41.9%
-0.8pp
FY2025
Operating Margin
-62.57%
-47.4pp
FY2025
Diluted EPS
-$0.94
-261.5%
FY2025
Operating Cash Flow
-$49.02M
-279.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $112.41M | $115.02M | $185.83M | $405.47M | $387.48M | $233.67M | $171.72M | $154.61M | $181.74M | $167.06M | $128.2M | $119.72M | $106.46M | $98.94M | $87.82M | $81.88M | $75.02M | $77.03M | |
| $64.55M | $66.82M | $106.44M | $233.82M | $239.04M | $116.07M | $69.85M | $60.02M | $68.13M | $68.11M | $40.17M | $39.43M | $39.84M | $40.35M | $32.25M | $30.16M | $27.66M | $29.9M | |
| $47.86M | $48.2M | $79.39M | $171.65M | $148.44M | $117.6M | $101.87M | $94.58M | $113.61M | $98.96M | $88.03M | $80.29M | $66.62M | $58.59M | $55.57M | $51.72M | $47.36M | $47.13M | |
| — | 41.9% | 42.72% | 42.33% | 38.31% | 50.33% | 59.32% | 61.18% | 62.51% | 59.23% | 68.66% | 67.07% | 62.58% | 59.22% | 63.28% | 63.16% | 63.13% | 61.19% | |
| $44.62M | $42.53M | $26.05M | $33.73M | $36.24M | $34.17M | $31.03M | $19.63M | $16.25M | $13.37M | $9.75M | $11.65M | $12.06M | $10.93M | $12.45M | $18.41M | $13.19M | $13.37M | |
| $26.26M | $26.12M | $30.99M | $36.32M | $49.24M | $44.75M | $34.46M | $31.87M | $30.61M | $28.53M | $29.65M | $35.09M | $41.12M | $46.47M | $37.09M | $22.38M | $20.73M | $21.22M | |
| $49.88M | $47.68M | $46.22M | $58.19M | $68.21M | $50.33M | $42.65M | $35.29M | $38.33M | $29.32M | $28.36M | $25.49M | $23.75M | $21.65M | $22.31M | $20.33M | $16.79M | $16.85M | |
| — | $300K | $700K | $2M | $2.3M | $3.3M | $3.25M | $2.52M | $2.62M | $2.64M | $2.54M | $2.7M | $3.18M | $3.53M | $3.9M | $1.96M | $502K | — | |
| $9.57M | $10.19M | $10.87M | $20.94M | $15.31M | $11.66M | $9.39M | $7.34M | $6.45M | $6.08M | $5.69M | $5.81M | $6.31M | $6.55M | $7.25M | $4.89M | $3.01M | $3.05M | |
| $101.88M | $120.17M | $107.64M | $138.97M | $170.59M | $127.76M | $107.05M | $75.97M | $85.18M | $58.72M | $67.76M | $72.24M | $71.43M | $70.75M | $71.84M | $61.11M | $50.71M | $55.92M | |
| -$54.02M | -$71.97M | -$28.25M | $32.68M | -$22.16M | -$10.16M | -$5.18M | $18.61M | $28.43M | $40.24M | $20.27M | $8.06M | -$4.8M | -$12.16M | -$16.27M | -$9.4M | -$3.35M | -$8.79M | |
| — | -62.57% | -15.2% | 8.06% | -5.72% | -4.35% | -3.01% | 12.04% | 15.64% | 24.09% | 15.81% | 6.73% | -4.51% | -12.29% | -18.53% | -11.48% | -4.47% | -11.42% | |
| -$44.45M | -$61.78M | -$17.38M | $53.62M | -$6.85M | $1.49M | $4.21M | $25.95M | $34.88M | $46.31M | $25.95M | $13.86M | $1.51M | -$5.61M | -$9.02M | -$4.51M | -$342K | -$5.74M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | $172K | $316K | $316K | $361.19K | |
| $6.27M | $8.08M | $11.47M | $5.86M | $1.57M | — | — | — | — | — | — | — | — | — | — | $63.99K | $151.76K | $737.89K | |
| $654K | $229K | -$380K | $17.84M | $3.45M | $872K | $1.65M | $2.72M | $3.29M | $794K | $58K | $774K | $531K | $200K | -$70K | $3000 | $173K | $1788 | |
| -$2.62M | -$2.34M | -$1.7M | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$46.63M | -$64.59M | -$16M | $56.26M | -$15.68M | -$9.29M | -$3.52M | $21.33M | $31.72M | $41.03M | $20.32M | $8.83M | -$4.27M | -$11.96M | -$16.51M | -$9.71M | -$3.5M | -$8.44M | |
| -$120K | $1.8M | $1.8M | $2.6M | $1.46M | $13.71M | $11.4M | $4.68M | $11.32M | $10.08M | $603K | $665K | $343K | -$772K | -$1.4M | -$869K | — | -$622.28K | |
| -$49.13M | -$68.73M | -$19.5M | $53.66M | -$17.13M | -$23M | -$14.92M | $16.66M | $20.4M | $30.95M | $19.72M | $8.17M | -$4.61M | -$11.19M | -$15.12M | -$8.84M | -$3.5M | -$7.81M | |
| — | -59.76% | -10.49% | 13.23% | -4.42% | -9.84% | -8.69% | 10.77% | 11.22% | 18.52% | 15.38% | 6.82% | -4.33% | -11.31% | -17.21% | -10.8% | -4.66% | -10.14% | |
| -$53.65M | -$62.78M | -$28.92M | $57.15M | -$25.49M | -$23.98M | -$11.88M | $23.23M | $12.03M | $34.83M | $21.14M | $376K | -$8.67M | -$14.32M | -$13.82M | -$10.57M | -$3.5M | -$7.78M | |
| USD/shares | -$0.70 | -$0.94 | -$0.26 | $0.73 | -$0.24 | -$0.32 | $0.22 | $0.27 | $0.33 | $0.52 | $0.35 | $0.14 | -$0.08 | -$0.20 | -$0.29 | -$0.19 | -$0.08 | — |
| USD/shares | -$0.70 | -$0.94 | -$0.26 | $0.72 | -$0.24 | -$0.32 | $0.22 | $0.27 | $0.33 | $0.51 | $0.35 | $0.14 | -$0.08 | -$0.20 | -$0.29 | -$0.19 | -$0.08 | — |
| shares | — | 73.49M | 74.43M | 73.35M | 72.51M | 71.98M | 67.51M | 61.68M | 61.11M | 59.05M | 55.62M | 56.4M | 55.95M | 55.56M | 51.46M | 46.91M | 46.19M | — |
| shares | — | 73.49M | 74.43M | 74.39M | 72.51M | 71.98M | 67.51M | 62.17M | 62.53M | 61.02M | 56.51M | 56.85M | 55.95M | 55.56M | 51.46M | 46.91M | 46.19M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $44.92M in buybacks.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 2.34×
EV/EBIT
—
Peer median 18.73×
P/E (TTM)
—
Peer median 25.38×
Peer medians compare against the 18 similar-size Medical Instruments & Supplies companies (of 46 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Diagnostics | $303,673,000 | $90,040,000 | $65,240,000 | $78,225,000 | $85,635,000 | — |
| Molecular Solutions | $83,806,000 | $143,634,000 | $106,481,000 | $76,380,000 | $96,108,000 | — |
| DNAG | — | — | — | — | — | $75,099,000 |
| OSUR | — | — | — | — | — | $91,965,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $78,252,000 | $139,161,000 | $361,660,000 | $350,206,000 | $188,383,000 | $130,835,000 | $107,279,000 | $136,847,000 |
| Africa | $23,993,000 | $32,745,000 | $29,254,000 | $18,152,000 | — | — | — | — |
| Europe | $7,393,000 | $8,424,000 | $8,111,000 | $11,536,000 | $13,799,000 | $12,068,000 | $11,752,000 | $11,062,000 |
| Other Foreign Countries | $5,383,000 | $5,497,000 | $6,447,000 | $7,585,000 | $31,492,000 | $28,818,000 | $35,574,000 | $33,834,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Product and Services | $109,055,000 | $184,611,000 | $402,222,000 | $378,047,000 | $226,897,000 | $166,381,000 | $148,073,000 | $165,428,000 |
| Other Revenues | $5,966,000 | $1,216,000 | $3,250,000 | $9,432,000 | $6,777,000 | $5,340,000 | $6,532,000 | $16,315,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Diagnostics | -$598,000 | -$57,177,000 | -$43,156,000 | $154,000 | -$15,188,000 | — |
| Molecular Solutions | -$22,359,000 | $47,013,000 | $37,979,000 | $18,457,000 | $43,617,000 | — |
| DNAG | — | — | — | — | — | $41,923,000 |
| OSUR | — | — | — | — | — | -$1,685,000 |
Operating Margin by Segment (%)
| Component | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Diagnostics | -0.2% | -63.5% | -66.1% | 0.2% | -17.7% | — |
| Molecular Solutions | -26.7% | 32.7% | 35.7% | 24.2% | 45.4% | — |
| DNAG | — | — | — | — | — | 55.8% |
| OSUR | — | — | — | — | — | -1.8% |